Novavax COVID-19 vaccine could be approved very soon, says EMA chief

The head of the European Medicines Agency (EMA) on Tuesday said that it could soon approve the COVID-19 vaccine developed by U.S. biotech company Novavax.

"The vaccine from Novavax could be authorised in the very near future," Emma Cooke told EU health ministers during a public session of a meeting in Brussels.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)